KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Depreciation & Amortization - Total: 2015-2024

Historic Depreciation & Amortization - Total for Medpace Holdings (MEDP) over the last 10 years, with Dec 2024 value amounting to $27.8 million.

  • Medpace Holdings' Depreciation & Amortization - Total fell 4.82% to $6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.4 million, marking a year-over-year increase of 1.27%. This contributed to the annual value of $27.8 million for FY2024, which is 15.25% up from last year.
  • Latest data reveals that Medpace Holdings reported Depreciation & Amortization - Total of $27.8 million as of FY2024, which was up 15.25% from $24.1 million recorded in FY2023.
  • Medpace Holdings' 5-year Depreciation & Amortization - Total high stood at $27.8 million for FY2024, and its period low was $11.7 million during FY2020.
  • Its 3-year average for Depreciation & Amortization - Total is $23.6 million, with a median of $24.1 million in 2023.
  • Data for Medpace Holdings' Depreciation & Amortization - Total shows a peak YoY skyrocketed of 39.29% (in 2020) over the last 5 years.
  • Yearly analysis of 5 years shows Medpace Holdings' Depreciation & Amortization - Total stood at $11.7 million in 2020, then spiked by 36.79% to $16.0 million in 2021, then rose by 18.71% to $19.0 million in 2022, then rose by 26.99% to $24.1 million in 2023, then rose by 15.25% to $27.8 million in 2024.